Literature DB >> 21648246

In vitro treatments for the theront stage of the ciliate protozoan Cryptocaryon irritans.

S M Picón-Camacho1, M R Ruiz de Ybáñez, A S Holzer, M Arizcun Arizcun, P Muñoz.   

Abstract

The ciliate protozoan Cryptocaryon irritans Brown, 1951, the 'marine white spot', causes one of the most important parasitic fish diseases, with extensive losses every year in mariculture and in the ornamental fish industry. In the present study, we explore the in vitro use of 8 different compounds against the theront (infective) stage of C. irritans; these compounds include extracts of natural products (epigallocatechin gallate (EGCG), L-DOPA, papain), peracetic acid-based compounds (Proxitane 5:23 and 15% peracetic acid, PAA), quinine-based compounds (quinacrine hydrochloride and chloroquine diphosphate) and hydrogen peroxide. All of these compounds had an effect on theront survival; however, only EGCG caused significant theront mortality when applied in doses > or =50 mg l(-1) and over a period of 3 h; papain caused a maximum theront mortality of <50%. We discuss the type of application and potential utility of the compounds tested as part of a management control strategy for C. irritans infections in marine aquaculture and the ornamental fish industry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21648246     DOI: 10.3354/dao02315

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  2 in total

1.  Glutathione metabolism in Cryptocaryon irritans involved in defense against oxidative stress induced by zinc ions.

Authors:  Zhi-Hong Zhong; Zhi-Cheng Li; Han Li; Qing-Kai Guo; Chen-Xi Wang; Ji-Zhen Cao; An-Xing Li
Journal:  Parasit Vectors       Date:  2022-09-07       Impact factor: 4.047

2.  Severe Natural Outbreak of Cryptocaryon irritans in Gilthead Seabream Produces Leukocyte Mobilization and Innate Immunity at the Gill Tissue.

Authors:  Laura Cervera; Carmen González-Fernández; Marta Arizcun; Alberto Cuesta; Elena Chaves-Pozo
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.